• 187
  • 24
  • Favorite

Biogen shares fell 1.2% in early trading

Tiger Newspress2021-12-22

Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.

Tokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.

In a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment24

  • cowsmile
    ·2021-12-23
    Nite
    Reply
    Report
  • Boink
    ·2021-12-23
    Long
    Reply
    Report
  • gil dina
    ·2021-12-23
    Oh no
    Reply
    Report
  • Rudyy
    ·2021-12-23
    Like
    Reply
    Report
  • DirtyGreen
    ·2021-12-23
    Wow
    Reply
    Report
  • AudTKH
    ·2021-12-23
    K
    Reply
    Report
  • ALLOYHUAT
    ·2021-12-23
    Like
    Reply
    Report
  • JesseC
    ·2021-12-23
    Ok
    Reply
    Report
  • windz123
    ·2021-12-23
    .
    Reply
    Report
  • Melodykjh
    ·2021-12-23
    Like
    Reply
    Report
  • Bevk
    ·2021-12-23
    Interesting article thanks for share
    Reply
    Report
    Fold Replies
  • 咸蛋超人POT
    ·2021-12-23
    The drug ha side effects
    Reply
    Report
  • zetheraine
    ·2021-12-23
    Buy or not?
    Reply
    Report
    Fold Replies
    • Veldin
      Ok
      2021-12-23
      Reply
      Report
    • Meowlisa
      Ok
      2021-12-23
      Reply
      Report
  • Bunifa Latif
    ·2021-12-23
    Nice
    Reply
    Report
  • AMDidass
    ·2021-12-23
    [Cool] 
    Reply
    Report
    Fold Replies
  • Galaxi
    ·2021-12-23
    What happened
    Reply
    Report
    Fold Replies
  • BBBBBBBBBB
    ·2021-12-23
    Ok
    Reply
    Report
    Fold Replies
    • Boink
      Ok
      2021-12-23
      Reply
      Report
  • peterob1
    ·2021-12-23
    [Miser] 
    Reply
    Report
  • Tgbdisciple
    ·2021-12-22
    Cool
    Reply
    Report
    Fold Replies
  • BBBBBBBBBB
    ·2021-12-22
    Ok
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial